Monoclonal Antibody (mABs) Therapeutics Market is Expected to Reach $497.5 billion | MarketsandMarkets™ Chicago, April 09, 2024 (GLOBE NEWSWIRE) -- Monoclonal Antibody (mABs) Therapeutics market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion...

Antibody Therapeutics Market to Witness Remarkable Growth with a CAGR of 13% during the Forecast Period | MarketDigits Richmond, Feb. 22, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, Antibody Therapeutics Market was valued USD 232 Billion in 2023 and projected to reach USD 535.8 Billion by 2030, growing at a...

Antibody Therapeutics Market is Expected to Reach $479.0 Billion | MarketsandMarkets. Chicago, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Antibody Therapeutics market in terms of revenue was estimated to be worth $247.3 Billion in 2023 and is poised to reach $479.0 billion by 2028, growing at...

Global Monoclonal Antibody Therapeutics Market Will Reach USD 218.97 Billion by 2023: Zion Market Research New York, NY, April 10, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases,...

Global Next-generation Antibody Therapeutics Market Will Reach US$ 6,761.1 Million by 2022: Persistence Market Research New York, June 29, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Persistence Market Research "Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody...